The Microbial Endocrinology of Pseudomonas aeruginosa: Inflammatory and Immune Perspectives
Pseudomonas aeruginosa is a major pathogen responsible for both acute and chronic infection. Known as a colonising pathogen of the cystic fibrosis (CF) lung, it is implicated in other settings such as bronchiectasis. It has the ability to cause acute disseminated or localised infection particularly in the immunocompromised. Human hormones have been highlighted as potential regulators of bacterial virulence through crosstalk between analogous “quorum sensing” (QS) systems present in the bacteria that respond to mammalian hormones. Pseudomonas aeruginosa is known to utilise interconnected QS systems to coordinate its virulence and evade various aspects of the host immune system activated in response to infection. Several human hormones demonstrate an influence on P. aeruginosa growth and virulence. This inter-kingdom signalling, termed “microbial endocrinology” has important implications for host–microbe interaction during infection and, potentially opens up novel avenues for therapeutic intervention. This phenomenon, supported by the existence of sexual dichotomies in both microbial infection and chronic lung diseases such as CF is potentially explained by sex hormones and their influence on the infective process. This review summarises our current understanding of the microbial endocrinology of P. aeruginosa, including its endogenous QS systems and their intersection with human endocrinology, pathogenesis of infection and the host immune system.
KeywordsPseudomonas aeruginosa Endocrinology Sex hormones Immunology Quorum sensing
Compliance with Ethical Standards
Conflict of interest
All authors have no conflicts of interest to disclose.
- Brunelleschi S (2016) Immune response and auto-immune diseases: gender does matter and makes the difference. Italian J Gender Specific Med 2:5–14Google Scholar
- Cole JN, Nizet V (2016) Bacterial evasion of host antimicrobial peptide defenses. Microbiol Spectr 4:413–443Google Scholar
- Kiseleva E, Novik G (2015) Role of type III secretory system and related exotoxins in infections induced by an opportunistic pathogen Pseudomonas aeruginosa. In: Méndez-Vilas A (ed) The battle against microbial pathogens: basic science, technological advances and educational programs. FORMATEX microbiology series N 5, vol 2. pp 733–744Google Scholar
- Lagoumintzis G, Christofidou M, Dimitracopoulos G et al (2003) Pseudomonas aeruginosa slime glycolipoprotein is a potent stimulant of tumor necrosis factor alpha gene expression and activation of transcription activators nuclear factor κB and activator protein 1 in human monocytes. Infect Immun 71:4614–4622PubMedPubMedCentralCrossRefGoogle Scholar
- Lagoumintzis G, Xaplanteri P, Dimitracopoulos G et al (2008) TNF-alpha induction by Pseudomonas aeruginosa lipopolysaccharide or slime-glycolipoprotein in human monocytes is regulated at the level of Mitogen-activated Protein Kinase activity: a distinct role of Toll-like receptor 2 and 4. Scand J Immunol 67:193–203PubMedCrossRefGoogle Scholar
- Leone M, Textoris J, Capo C and Mege J-L (2012) Sex hormones and bacterial infections. In: Dubey R (ed) Sex hormones. InTech. https://doi.org/10.5772/26871. https://pdfs.semanticscholar.org/a7cc/19ed33b3596e9536f7951a399ad58cc22194.pdf. Accessed 8 July 2017
- Maseda H, Sawada I, Saito K et al (2004) Enhancement of the mexAB-oprM efflux pump expression by a quorum-sensing autoinducer and its cancellation by a regulator, MexT, of the mexEF-oprN efflux pump operon in Pseudomonas aeruginosa. Antimicrob Agents Chemother 48:1320–1328PubMedPubMedCentralCrossRefGoogle Scholar
- Ortona E, Delunardo F, Maselli A et al (2015) Sex hormones and gender disparity in immunity and autoimmunity. Italian J Gender Specific Med 1:45–50Google Scholar
- Vogel G (2017) Meet WHO’s dirty dozen: the 12 bacteria for which new drugs are most urgently needed. Science Magazine, 27 Feb 2017. https://doi.org/10.1126/science.aal0829
- Weiner LM, Webb AK, Limbago B et al (2016) Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2011–2014. Infect Control Hosp Epidemiol 37:1288–1301PubMedCrossRefGoogle Scholar